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Antimicrobial resistance is an increasing threat to global health. Evidence for this
trend is generated in microbiological laboratories through testing microorganisms for re-
sistance against antimicrobial agents. International standards and guidelines are in place
for this process as well as for reporting data on (inter-)national levels. However, there is a
gap in the availability of standardized and reproducible tools for working with laboratory
data to produce the required reports. It is known that extensive efforts in data cleaning
and validation are required when working with data from laboratory information sys-
tems. Furthermore, the global spread and relevance of antimicrobial resistance demands
to incorporate international reference data in the analysis process.
In this paper, we introduce the AMR package for R that aims at closing this gap
by providing tools to simplify antimicrobial resistance data cleaning and analysis, while
incorporating international guidelines and scientifically reliable reference data. The AMR
package enables standardized and reproducible antimicrobial resistance analyses, includ-
ing the application of evidence-based rules, determination of first isolates, translation of
various codes for microorganisms and antimicrobial agents, determination of (multi-drug)
resistant microorganisms, and calculation of antimicrobial resistance, prevalence and fu-
ture trends. The AMR package works independently of any laboratory information system
and provides several functions to integrate into international workflows (e.g. WHONET
software provided by the World Health Organization).
Keywords: Antimicrobial resistance, data analysis, R, software, epidemiology.
1. Introduction
Antimicrobial resistance is a global health problem and of great concern for human medicine,
veterinary medicine, and the environment alike. It is associated with significant burdens to
both patients and health care systems. Current estimates show the immense dimensions we
are already facing, such as claiming at least 50,000 lives due to antimicrobial resistance each
year across Europe and the US alone (O’Neill 2014). Although estimates for the burden
.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/810622doi: bioRxiv preprint 
2 AMR - An R Package for Working with Antimicrobial Resistance Data
through antimicrobial resistance and their predictions are disputed (de Kraker et al. 2016)
the rising trend is undeniable (CDC 2019), thus calling for worldwide efforts on tackling this
problem.
Surveillance programs and reliable data are key for controlling and streamlining these efforts.
Surveillance data of antimicrobial resistance at higher levels (national or international) usually
comprise aggregated numbers. The basis of this information is generated and stored at local
microbiological laboratories where isolated microorganisms are tested for their susceptibility
to a whole range of antimicrobial agents. The efficacy of these agents against microorganisms
is nowadays interpreted as follows (EUCAST 2019):
• R (“resistant”) - there is a high likelihood of therapeutic failure;
• S (“susceptible, standard dosing regimen”) - there is a high likelihood of therapeutic
success using a standard dosing regimen of an antimicrobial agent;
• I (“susceptible, increased exposure”) - there is a high likelihood of therapeutic success,
but only when exposure to an antimicrobial agent is increased by adjusting the dosing
regimen or its concentration at the site of infection.
Generally, antimicrobial resistance is defined as the proportion of R (%R), while antimicrobial
susceptibility is defined as the proportion of S and I (%SI). Today, the two major guideline
institutes to define the international standards on antimicrobial resistance are the European
Committee on Antimicrobial Susceptibility Testing (EUCAST) (Leclercq et al. 2013) and
the Clinical and Laboratory Standards Institute (CLSI) (Clinical and Laboratory Standards
Institute 2014). The guidelines from these two institutes are adopted by 94% of all countries
reporting antimicrobial resistance to the WHO (World Health Organization 2018a).
Although these standardized guidelines are in place on the laboratory level for the data gen-
eration process, stored data in laboratory information systems are often not yet suitable
for data analysis. Laboratory information systems are often designed to fit billing purposes
rather than epidemiological data analysis. Furthermore, (inter-)national surveillance is hin-
dered by inadequate standardization of epidemiological definitions, different types of samples
and data collection, settings included, microbiological testing methods (including suscepti-
bility testing), and data sharing policies (Tacconelli et al. 2018). The necessity of accurate
data analysis in the field of antimicrobial resistance has just recently been further underlined
(Limmathurotsakul et al. 2019). Antimicrobial resistance analyses require a thorough under-
standing of microbiological tests and their results, the biological taxonomy of microorganisms,
the clinical and epidemiological relevance of the results, their pharmaceutical implications,
and (inter-)national standards and guidelines for working with and reporting antimicrobial
resistance.
Here, we describe the AMR package for R, which has been developed to standardize clean
and reproducible antimicrobial resistance data analyses using international standardized rec-
ommendations (Leclercq et al. 2013; Clinical and Laboratory Standards Institute 2014) while
incorporating scientifically reliable reference data about valid laboratory outcome, antimicro-
bial agents, and the complete biological taxonomy of microorganisms. The AMR package
provides solutions and support for these aspects while being independent of underlying lab-
oratory information systems, thereby democratizing the analysis process. Developed in R
and available on the Comprehensive R Archive Network (CRAN) since February 22nd 2018
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(Berends et al. 2019), the AMR package enables reproducible workflows as described in other
fields, such as environmental science (Lowndes et al. 2017). The AMR package provides a
new technical instrument to aid in curbing the global threat of antimicrobial resistance. Fur-
thermore, local and regional data in the laboratories can now become relevant in any setting
for public health. To the best of our knowledge, no other R package with this purpose is
available on CRAN or Bioconductor.
The following sections describe the functionality of the AMR package according to its core
functionalities for transforming, enhancing, and analyzing antimicrobial resistance data using
scientifically reliable reference data.
2. Antimicrobial resistance data
Microbiological tests can be performed on different specimens, such as blood or urine samples
or nasal swabs. After arrival at the microbiological laboratory, the specimens are traditionally
cultured on specific media, such as blood agar. If a microorganism can be isolated from these
media, it is tested against several antimicrobial agents. Based on the minimal inhibitory
concentration (MIC) of the respective drug and interpretation guidelines, such as guidelines
by EUCAST (Leclercq et al. 2013) and CLSI (Clinical and Laboratory Standards Institute
2014), test results are reported as “resistant” (R), “susceptible” (S) or “susceptible, increased
exposure” (I). A typical data structure is illustrated in Table 1 (Leclercq et al. 2013).
Table 1: Example of an antimicrobial resistance report.
patient date test_no specimen mo PEN AMC CIP
000001 2019-03-08 100 blood esccol R I S
000001 2019-03-09 101 blood esccol R I S
000002 2019-03-08 102 blood staaur R S -
000003 2019-03-08 103 urine pseaer R R R
Abbreviations: R = resistant, S = susceptible, I = susceptible, increased exposure,
mo = microorganism, PEN = penicillin, AMC = amoxicillin/clavulanic acid, CIP = ciprofloxacin
For the first two rows, the information should be read as: Escherichia coli (mo code = esccol)
was isolated from blood of patient 000001 and was found to be resistant to penicillin, and
susceptible to amoxicillin/clavulanic acid and ciprofloxacin. However, often (especially when
merging sources) data is reported in ambiguous formats as exemplified in Table 2. It is crucial
that source data can be analyzed in a relibale way, especially when the outcome will be used to
evaluate patient treatment options. This requires reproducible and field-specific, specialized
data cleaning and transforming.
The AMR package aims at providing a standardized and automated way of cleaning, trans-
forming, and enhancing these typical data structures (Table 1 and 2), independent of the
underlying data source. Processed data would be similar to Table 3 that highlights several
package functionalities in the sections below.
3. Antimicrobial resistance data transformation
The AMR package follows the rationale of tidyverse packages as authored by Wickham et al.
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Table 2: Antimicrobial resistance report example - ambiguous formats.
patient date test_no specimen mo PEN AMC CIP
1 2019-03-08 100 blood esccol R I S
1 2019-03-09 101 blood esccol R I S
2 2019-03-08 102 blood StaAur >8 (R)* <0.01 (S)* .
00003 2019-03-08 103 urine P. aeru. R S** S
* Mixed reporting of minimal inhibitory concentration (MIC) and susceptibility interpretation of
MIC value
** False reporting; Pseudomonas aeruginosa (mo = P. aeru.) is intrinsically resistant to
amoxicillin/clavulanic acid (AMC)
Abbreviations: R = resistant, S = susceptible, I = susceptible, increased exposure,
mo = microorganism, PEN = penicillin, AMC = amoxicillin/clavulanic acid, CIP = ciprofloxacin
Table 3: Enhanced antimicrobial resistance report example.
patient date test_no specimen moa PENb AMCb CIPb first_isolatec named gram_staine
000001 2019-03-08 100 blood B_ESCHR_COL R I S TRUE Escherichia coli Gram-negative
000001 2019-03-09 101 blood B_ESCHR_COL R I S FALSE Escherichia coli Gram-negative
000002 2019-03-08 102 blood B_STPHY_AUR R S NA TRUE Staphylococcus aureus Gram-positive
000003 2019-03-08 103 urine B_PSDMN_AER R R S TRUE Pseudomonas aeruginosa Gram-negative
a) as.mo() function




Abbreviations: R = resistant, S = susceptible, I = susceptible, increased exposure,
mo = microorganism, PEN = penicillin, AMC = amoxicillin/clavulanic acid, CIP = ciprofloxacin
(2019a). Most functions take a ’data.frame’ or ’tibble’ as input, support piping (%>%)
operations, can work with quasi-quotations, and can be integrated into dplyr workflows, such
as mutate() to create new variables and group_by() to group by variables.
3.1. Working with taxonomically valid microorganism names
Coercing is a computational process of forcing output based on an input. For microor-
ganism names, coercing user input to taxonomically valid microorganism names is crucial
to ensure correct interpretation and to enable grouping based on taxonomic properties.
To this end, the AMR package includes all microbial entries from The Catalogue of Life
(http://www.catalogueoflife.org), the most comprehensive and authoritative global index of
species currently available (Roskov et al. 2019). It holds essential information on the names,
relationships, and distributions of more than 1.9 million species. The integration of it into
the AMR package is described in Section 8.
The as.mo() function makes use of this underlying data to transform a vector of characters
to a new class ’mo’ of taxonomically valid microorganism name. The resulting values are
microbial IDs, which are human-readable for the trained eye and contain information about
the taxonomic kingdom, genus, species, and subspecies (Figure 1).
The as.mo() function uses several coercion rules for fast and logical results. It assesses the
input matching criteria in the following order:
1. Human pathogenic prevalence: the function starts with more prevalent microorganisms,
followed by less prevalent ones;
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subspecies, a 4-5 letter acronym
species, a 4-5 letter acronym
genus, a 5-7 letter acronym
kingdom: A (Archaea), AN (Animalia), B (Bacteria),
C (Chromista), F (Fungi), or P (Protozoa)
Microbial ID Full name
B_KLBSL Klebsiella
B_KLBSL_PNMN Klebsiella pneumoniae
B_KLBSL_PNMN_RHNS Klebsiella pneumoniae rhinoscleromatis
Figure 1: The structure of a typical microbial ID as used in the AMR package. An ID
consists of two to four elements, separated by an underscore. The first element is the abbre-
viation of the taxonomic kingdom. The remaining elements consist of abbreviations of the
lowest taxonomic levels of every microorganism: genus, species (if available) and subspecies
(if available). Abbreviations used for the microbial IDs of microorganism names were created
using the base R function abbreviate().
2. Taxonomic kingdom: the function starts with determining Bacteria, then Fungi, then
Protozoa, then others;
3. Breakdown of input values to identify possible matches.
This will lead to the effect that e.g. "E. coli" (a highly prevalent microorganism found
in humans) will return the microbial ID of Escherichia coli and not Entamoeba coli (a less
prevalent microorganism in humans), although the latter would alphabetically come first.
In addition, the as.mo() function can differentiate four levels of uncertainty to guess valid
results:
• Uncertainty level 0: no additional rules are applied;
• Uncertainty level 1: allow previously accepted (but now invalid) taxonomic names and
minor spelling errors;
• Uncertainty level 2 (default): allow all of level 1, strip values between brackets, inverse
the words of the input, strip off text elements from the end keeping at least two elements;
• Uncertainty level 3: allow all of level 1 and 2, strip off text elements from the end, allow
any part of a taxonomic name.
These rules consider the prevalence of microorganisms in humans. The grouping into three
prevalence groups is based on experience from several microbiological laboratories in the
Netherlands in conjunction with international reports on pathogen prevalence (de Greeff et al.
2019; European Centre for Disease Prevention and Control 2010; World Health Organiza-
tion 2018a). Group 1 (most prevalent microorganisms) consists of all microorganisms where
the taxonomic class is Gammaproteobacteria or where the taxonomic genus is Enterococcus,
Staphylococcus or Streptococcus. This group consequently contains all common Gram-negative
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bacteria, such as Pseudomonas and Legionella and all species within the order Enterobac-
terales. Group 2 consists of all microorganisms where the taxonomic phylum is Proteobacte-
ria, Firmicutes, Actinobacteria or Sarcomastigophora, or where the taxonomic genus is Ab-
sidia, Acremonium, Actinotignum, Alternaria, Anaerosalibacter, Apophysomyces, Arachnia,
Aspergillus, Aureobacterium, Aureobasidium, Bacteroides, Basidiobolus, Beauveria, Blastocys-
tis, Branhamella, Calymmatobacterium, Candida, Capnocytophaga, Catabacter, Chaetomium,
Chryseobacterium, Chryseomonas, Chrysonilia, Cladophialophora, Cladosporium, Conidiobo-
lus, Cryptococcus, Curvularia, Exophiala, Exserohilum, Flavobacterium, Fonsecaea, Fusarium,
Fusobacterium, Hendersonula, Hypomyces, Koserella, Lelliottia, Leptosphaeria, Leptotrichia,
Malassezia, Malbranchea, Mortierella, Mucor, Mycocentrospora, Mycoplasma, Nectria, Ochro-
conis, Oidiodendron, Phoma, Piedraia, Pithomyces, Pityrosporum, Prevotella, Pseudallescheria,
Rhizomucor, Rhizopus, Rhodotorula, Scolecobasidium, Scopulariopsis, Scytalidium,
Sporobolomyces, Stachybotrys, Stomatococcus, Treponema, Trichoderma, Trichophyton,
Trichosporon, Tritirachium or Ureaplasma. Group 3 consists of all other microorganisms.
To support organization specific codes, users can specify a custom reference ’data.frame’ for
looking up codes, that can be set with as.mo(..., reference_df = ...). This process can
be automated by users with the set_mo_source() function.
Properties of microorganisms
The package contains functions to return a specific (taxonomic) property of a microorganism
from the microorganisms data set (see Section 8). Using functions that start with mo_* can be
used to retrieve the most recently defined taxonomic properties of any microorganism quickly
and conveniently. These functions rely on as.mo() internally: mo_name(), mo_fullname(),
mo_shortname(), mo_subspecies(), mo_species(), mo_genus(), mo_family(), mo_order(),
mo_class(), mo_phylum(), mo_kingdom(), mo_type(), mo_gramstain(), mo_ref(),
mo_authors(), mo_year(), mo_rank(), mo_taxonomy(), mo_synonyms(), mo_info() and
mo_url(). Determination of the Gram stain, with mo_gramstain(), is based on the tax-
onomic subkingdom and phylum. According to Cavalier-Smith (2002), who defined the sub-
kingdoms Negibacteria and Posibacteria, only the following phyla are Posibacteria: Acti-
nobacteria, Chloroflexi, Firmicutes and Tenericutes. Bacteria from these phyla are con-
sidered Gram-positive - all other bacteria are considered Gram-negative. Gram stains are
only relevant for species within the kingdom of Bacteria. For species outside this kingdom,
mo_gramstain() will return NA.
3.2. Working with antimicrobial names or codes
The AMR package includes the antibiotics data set, which comprises common laboratory
information system codes, official names, ATC (Anatomical Therapeutic Chemical) codes,
defined daily doses (DDD) and more than 5,000 trade names of 452 antimicrobial agents (see
Section 8). The ATC code system and the reference list for DDDs have been developed and
made available by the World Health Organization Collaborating Centre for Drug Statistics
Methodology (WHOCC) to standardize pharmaceutical classifications (WHO Collaborating
Centre for Drug Statistics Methodology 2018). All agents in the antibiotics data set have
a unique antimicrobial ID, which is based on abbreviations used by the European Antimi-
crobial Resistance Surveillance Network (EARS-Net), the largest publicly funded system for
antimicrobial resistance surveillance in Europe (European Centre for Disease Prevention and
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Control 2018). Furthermore, the AMR package includes the antivirals data seta containing
antiviral agents, which is also described in Section 8.
Properties of antimicrobial agents
It is a common task in microbiological data analyses (and other clinical or epidemiological
fields) to work with different antimicrobial agents. The AMR package provides several func-
tions to translate inputs such as ATC codes, abbreviations, or names in any direction. Using
as.ab(), any input will be transformed to an antimicrobial ID of class ’ab’. Helper functions
are available to get specific properties of antimicrobial IDs, such as ab_name() getting the
official name, ab_atc() the ATC code, or ab_cid() the CID (Compound ID) used by Pub-
Chem (Kim et al. 2019). Trade names can be also used as input. For example, the input




R> as.ab(c("Amoxil", "dispermox", "amox", "J01CA04"))
Class 'ab'







Filtering data based on classes of antimicrobial agents
The application of the ATC classification system also enables grouping of antimicrobial agents
for data analyses. Data sets with microbial isolates can be filtered on isolates with specific
results for tested antimicrobial agents in a specific antimicrobial class. For example, using
filter_cephalosporins(result = "R") returns data of all isolates with tested resistance
to any of the available antimicrobial agents in in the group of cephalosporins.
3.3. Other new S3 classes
S3 classes are object oriented (OO) systems available in R. The classes ’mo’ and ’ab’ that are
discussed above are S3 classes, which means that they allow different types of output based on
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the user input. Three other new S3 classes that come with this package are ’mic’, ’disk’, and
’rsi’. The ’mic’ class can be used to clean MIC (minimal inhibitory concentration) values.
MIC values are susceptibility test results measured by microbiological laboratory equipment
to determine at which minimum antimicrobial drug concentration 99.9% of a microorganism is
inhibited in growth. These concentrations are often capped at a minimum and maximum, such
as <= 0.02 mg/ml and >= 32 mg/ml, respectively. The ’mic’ class, an ordered ’factor’,
keeps these operators while still ordering all possible outcomes correctly, so that e.g. "<=
0.02" will be considered lower than "0.04".
Another susceptibility testing method is the use of drug diffusion disks, which are small tablets
containing a specified concentration of antimicrobial agents. These disks are applied onto a
solid growth medium, or a specific agar plate. After 24 hours of incubation, the diameter of
the growth inhibition around a disk can be measured in millimeters with a ruler. The ’disk’
class can be used to clean these kinds of measurements, since they should always be valid
numeric values between 8 and 50.
The higher the MIC or the smaller the growth inhibition diameter, the more active substance
of an antimicrobial drug is needed to inhibit cell growth (i.e. the higher the antimicrobial
resistance of the tested isolate against the tested antimicrobial agent). At high MICs and
small diameters, guidelines interpret the microorganism as “resistant” (R) to the tested an-
timicrobial agent. At low MICs and wide diameters, guidelines interpret the microorganism
as “susceptible” (S) to the tested antimicrobial agent. In between, the microorganism is clas-
sified as “susceptible, increased exposure” (I). For these three interpretations the ’rsi’ class
has been developed. When using as.rsi() on MIC values (of class ’mic’) or disk diffusion
diameters (of class ’disk’), the values will be interpreted according to the guidelines from the
CLSI or EUCAST (all guidelines between 2011 and 2019 are included in the AMR package)
(Clinical and Laboratory Standards Institute 2019; The European Committee on Antimi-
crobial Susceptibility Testing 2019). Guidelines can be changed by setting the guidelines
argument.
R> # Low MIC value
R> as.rsi(as.mic(2), "E. coli", "ampicillin", guideline = "EUCAST 2019")
Class 'rsi'
[1] S
R> # High MIC value
R> as.rsi(as.mic(32), "E. coli", "ampicillin", guideline = "EUCAST 2019")
Class 'rsi'
[1] R
When using the as.rsi() function on existing antimicrobial interpretations, it tries to coerce
the input to the values “S”, “I”, or “R”. These values can in turn be used to calculate the
proportion of antimicrobial resistance.
3.4. Interpretative rules by EUCAST
Next to supplying guidelines to interpret raw MIC values, the EUCAST has developed a set
of expert rules to assist clinical microbiologists in the interpretation and reporting of antimi-
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crobial susceptibility tests (Leclercq et al. 2013). The rules comprise assistance on intrinsic
resistance, exceptional phenotypes, and interpretive rules. The AMR package covers intrinsic
resistant and interpretive rules for data transformation and standardization purposes. The
first prevents false susceptibility reporting by providing a list of organisms with known intrin-
sic resistance to specific antimicrobial agents (e.g. cephalosporin resistance of all enterococci).
Interpretative rules apply inference from established resistance mechanisms (Winstanley and
Courvalin 2011; Courvalin 1992, 1996; Livermore et al. 2001). Both groups of rules are based
on classic IF THEN statements (e.g. IF Enterococcus spp. resistant to ampicillin THEN
report as resistant to carbapenems). Some rules provide assistance for further actions when
certain resistance has been detected, i.e. performing additional testing of the isolated mi-
croorganism. The AMR package function eucast_rules() can apply all EUCAST rules that
do not rely on additional clinical information, such as additional information on patients’
diagnoses. Applied changes can be reviewed by setting the argument eucast_rules(...,
verbose = TRUE). Table 2 and 3 highlight the transformation for the reporting of AMX = S
in patient_id = 000003 to the correct report according to EUCAST rules of AMX = R.
3.5. Working with defined daily doses (DDD)
DDDs are essential when standardizing antimicrobial consumption analysis for inter-institu-
tional or international comparison. The official DDDs are published by the WHOCC and
subject to regular updates (WHO Collaborating Center for Drug Statistics Methodology
2019). Other metrics exist such as the recommended daily dose (RDD) or the prescribed
daily dose (PDD). However, DDDs are the only metric that is independent of a patient’s
disease and therapeutic choices and thus suitable for the AMR package.
Functions from the atc_online_*() family take any text as input that can be coerced
with as.ab() (i.e. to class ’ab’). Next, the functions access the WHOCC online registry
(WHO Collaborating Center for Drug Statistics Methodology 2019) (internet connection re-
quired) and download the property defined in the arguments (e.g. administration = "O"
or administration = "P" for oral or parenteral administration and property = "ddd" or
property = "groups" to get DDD or the group of the selected antimicrobial defined by its
ATC code).
R> atc_online_ddd("amoxicillin", administration = "O")
[1] 1.5
R> atc_online_groups("amoxicillin")
[1] "ANTIINFECTIVES FOR SYSTEMIC USE"
[2] "ANTIBACTERIALS FOR SYSTEMIC USE"
[3] "BETA-LACTAM ANTIBACTERIALS, PENICILLINS"
[4] "Penicillins with extended spectrum"
4. Enhancing antimicrobial resistance data
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4.1. Determining first isolates
Determining antimicrobial resistance or susceptibility can be done for a single drug (mono-
therapy) or multiple drugs (combination therapy). The calculation of antimicrobial resistance
statistics is dependent on two prerequisites: the data should only comprise the first isolates
and a minimum required number of 30 isolates should be met for every stratum in further
analysis (Clinical and Laboratory Standards Institute 2014).
An isolate is a microorganism strain cultivated on specified growth media in a laboratory,
so its phenotype can be determined. First isolates are isolates of any species found first in
a patient per episode, regardless of the body site or the type of specimen (such as blood
or urine) (Clinical and Laboratory Standards Institute 2014). The selection on first isolates
(using function first_isolate()) is important to prevent selection bias, as it would lead
to overestimated or underestimated resistance to an antimicrobial agent. For example, if
a patient is admitted with a multi-drug resistant microorganism and that microorganism is
found in five different blood cultures the following week, it would overestimate resistance if all
isolates were to be counted. The episode in days can be set with the argument episode_days,
which defaults to 365 as suggested by the Clinical and Laboratory Standards Institute (2014)
guideline.
4.2. Determining multi-drug resistant organisms (MDRO)
Definitions of multi-drug resistant organisms (MDRO) are regulated by national and interna-
tional expert groups and differ between nations. The AMR package provides the functionality
to quickly identify MDROs in a data set using the mdro() function. Guidelines can be set with
the argument guideline. At default, it applies the guideline as proposed by Magiorakos et al.
(2012). Their work describes the definitions for bacteria being ‘MDR’ (multi-drug-resistant),
‘XDR’ (extensively drug-resistant) or ‘PDR’ (pandrug-resistant). These definitions are widely
adopted (Abat et al. 2018) and known in the field of medical microbiology.
Other guidelines currently supported are the international EUCAST guideline (guideline =
"EUCAST", European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2016)),
the international WHO guideline on the management of drug-resistant tuberculosis (guideline
= "TB", World Health Organization (2014)), and the national guidelines of The Netherlands
(guideline = "NL", Werkgroep Infectiepreventie (WIP) (2011)), and Germany (guideline
= "DE", Müller et al. (2015)).
Some guidelines require a minimum availability of tested antimicrobial agents per isolate.
This is needed to prevent false-negatives, since no reliable determination can be performed on
only a few test results. This required minimum defaults to 50%, but can be set by the user
with the pct_minimum_classes. Isolates that do not meet this requirement will be skipped
for determination and will return NA (not applicable), with an informative warning printed
to the console.
The rules are applied per row of the data. The mdro() function automatically identifies
the variables containing the microorganism codes and antimicrobial agents based on the
guess_ab_col() function. Following the guideline set by the user, it analyzes the specific
antimicrobial resistance of a microorganism and flags that microorganism accordingly. The
outcome is demonstrated in Table 4, where the first row is an MDRO according to the Dutch
guidelines (Werkgroep Infectiepreventie (WIP) 2011).
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Table 4: Example of a multi-drug resistant organism (MDRO) in a data set identified by
applying Dutch guidelines.
mo AMC GEN TOB CIP MFX MDRO
B_ESCHR_COLI S R R R R Positive
B_ESCHR_COLI R S R R S Negative
B_ESCHR_COLI S S S R S Negative
Abbreviations: mo = microorganism, AMC = amoxicilline/clavulanic acid
GEN = gentamicin, TOB = tobramycin, CIP = ciprofloxacin, MFX = moxifloxacin,
MDRO = multi-drug resistant organism, B_ESCHR_COLI = microorganism code of
Escherichia coli
The returned value is an ordered ’factor’ with the levels ’Negative’ < ’Positive, unconfirmed’
< ’Positive’. For some guideline rules that require additional testing (e.g. molecular confir-
mation), the level ’Positive, unconfirmed’ is returned.
Multi-drug resistant tuberculosis
Tuberculosis is a major threat to global health caused by Mycobacterium tuberculosis (MTB)
and is one of the top ten causes of death worldwide (World Health Organization 2018b).
Exceptional antimicrobial resistance in MTB is therefore of special interest. To this end,
the international WHO guideline for the classification of drug resistance in MTB (World
Health Organization 2014) is included in the AMR package. The mdr_tb() function is a
convenient wrapper around mdro(..., guideline = "TB"), which returns an other ordered
’factor’ than other mdro() functions. The output will contain the ’factor’ levels ’Negative’
< ’Mono-resistant’ < ’Poly-resistant’ < ’Multi-drug-resistant’ < ’Extensive drug-
resistant’, following the WHO guideline.
5. Analyzing antimicrobial resistance data
5.1. Calculation of antimicrobial resistance
The AMR package contains several functions for fast and simple resistance calculations of
bacterial or fungal isolates. A minimum number of available isolates is needed for the relia-
bility of the outcome. The CLSI guideline suggests a minimum of 30 available first isolates
irrespective of the type of statistical analysis (Clinical and Laboratory Standards Institute
2014). Therefore, this number is used as the default setting for any function in the pack-
age that calculates antimicrobial resistance or susceptibility, which can be changed with the
minimum argument in all applicable functions.
Counts
The AMR package relies on the concept of tidy data (Wickham 2014), although not strictly
following its rules (one row per test rather than one row per observation). Function names
to calculate the number of available isolates follow these general resistance interpretation
standards with count_S(), count_I(), and count_R() respectively. Combinations of an-
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timicrobial resistance interpretations can be counted with count_SI() and count_IR(). All
these functions take a vector of interpretations of the class ’rsi’ (as discussed above) or are
internally transformed with as.rsi(). The returned value is the sum of the respective in-
terpretation in the selected test column. All count_*() functions support quasi-quotation
with pipes, grouped variables, and can be used with dplyr::summarize() (Wickham et al.
2019b).
Proportions
Calculation of antimicrobial resistance is carried out by counting the number of first resistant
isolates (interpretation of “R”) and dividing it by the number of all first isolates, see Formula 1.
This is implemented in the proportion_R() function. To calculate antimicrobial susceptibil-
ity, the number of susceptible first isolates (interpretation of “S” and “I”) has to be counted
and divided by the number of all first isolates, which is implemented in the proportion_SI()
function. For convenience, the resistance() function is an alias of the proportion_R()




where x is an antimicrobial agent, z is an antimicrobial interpretation (“S”, “I”, or “R”) and
R is the antimicrobial resistance.
The functions proportion_R(), proportion_IR(), proportion_I(), proportion_SI(), and
proportion_S() follow the same logic as the count_*() functions and all return a vector
of class ’double’ with values between 0 and 1. The argument minimum defines the minimal
allowed number of available (tested) isolates (default: minimum = 30). Any number below
the set minimum will return NA with a warning.
For the proportion of empiric susceptibility for more than one antimicrobial agent, the total
number of first isolates where at least one agent was tested as “S” or “I” must be divided
by the number of first isolates tested where all agents were tested for any interpretation (see




where x and y are antimicrobial agents, z is an antimicrobial interpretation: “S”, “I”, or “R”
and R is the antimicrobial resistance.
Based on Formula 1, the overall resistance and susceptibility of antimicrobial agents like
gentamicin (GEN) and amoxicillin (AMX) can be calculated using the following syntax. The
example_isolates is an example data set included in the AMR package, see Section 8. The
n_rsi() function is analogous to the n() function of the dplyr package. It counts the number




+ summarize(r_gen = proportion_R(GEN),
+ r_amx = proportion_R(AMX),
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Table 5: Example calculation for determining empiric susceptibility (%SI) for more than one
antimicrobial agent.
Antimicrobial agent All isolates Only isolates tested for both agents(only_all_tested = FALSE) (only_all_tested = TRUE)
Agent A Agent B Include as Include as Include as Include asnumerator denominator numerator denominator
S or I or R S or I x x x x
R R x x
N/A S or I x x
N/A R or N/A
Abbreviations: R = resistant, S = susceptible, I = susceptible, increased exposure,
N/A = not tested or missing
+ n_gen = n_rsi(GEN),
+ n_amx = n_rsi(AMX),
+ n_total = n())
r_gen r_amx n_gen n_amx n_total
1 0.2458221 0.5557364 1855 1229 2000
This output reads: the resistance to gentamicin of all isolates in the example_isolates
data set is RGEN = 24.6%, based on 1855 out of 2000 available isolates. This means the
susceptibility is 1− RGEN = 75.4%. The susceptibility to amoxicillin is 1− RAMX = 55.6%
based on 1229 isolates.
To calculate the effect of combination therapy, i.e. treating patients with multiple agents at
the same time, all proportion_*() functions can handle multiple variables as arguments.
For example, to calculate the empiric susceptibility of a combination therapy comprising
gentamicin (GEN) and amoxicillin (AMX):
R> example_isolates %>%
+ summarize(si_gen_amx = proportion_SI(GEN, AMX),
+ n_gen_amx = n_rsi(GEN, AMX),
+ n_total = n())
si_gen_amx n_gen_amx n_total
1 0.9328603 1919 2000
This leads to the conclusion that combining gentamicin with amoxicillin would cover 93.3%
based on 1919 out of 2000 available isolates, which is 17.9% more than when treating with
gentamicin alone (1−RGEN = 75.4%). With these functions, exact calculations can be done
to evaluate the empiric success of inhibiting growth of microorganisms, by treating them with
specified antimicrobial agents.
5.2. Prediction of antimicrobial resistance
The AMR package can handle several different regression models that can be used to pre-
dict antimicrobial resistance. The resistance_predict() function uses dates (argument
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col_date) and a selected antimicrobial agent (argument col_ab) to estimate resistance rates
of a specified number of upcoming years (default: year_max = 10). The user needs to spec-
ify the statistical model by setting the model argument. Valid options are generalized linear
models with a binomial distribution or Poisson distribution, or a linear regression model.
Furthermore, it is required to decide on the choice of interpreting isolates that are “suscep-
tible, increased exposure” as “susceptible isolates” (default: I_as_S = TRUE). The minimum
number of isolates per year defaults to 30 and can be set with the minimum argument.
The resistance_predict() function returns a ’data.frame’ with an extra S3 class
’resistance_predict’ and contains the following columns: year, value, se_min (the lower
bound of the standard error with a minimum of 0), se_max (the upper bound of the standard
error with a maximum of 1), observations (the total number of observations in the respective
year, i.e. “S” + “I” + “R”), observed (the original observed resistant percentages), and
estimated (the estimated resistant percentages calculated by the model). Furthermore, the
model itself is available as an attribute: attributes(x)$model.
5.3. Plotting of antimicrobial resistance
The AMR package contains simple plotting functionalities to visualize antimicrobial resis-
tance data. The geom_rsi() function for plotting data containing antimicrobial test results
is extending the ggplot2 package (Wickham 2016) with a new so-called ’geom’, geom_rsi().
The output is fully editable and follows the common ggplot2 code. Arguments include
position, fill, and facets (relying on ggplot2::facet_wrap()). Moreover, the argument
translate_ab uses ab_name() to translate abbreviations of antimicrobial agents into official
names. Figure 2 demonstrates an example plotting function with a selection of antimicrobial
agents commonly used to treat urinary tract infections.
R> library(ggplot2)
R> example_isolates %>%
+ select(AMX, NIT, FOS, TMP, CIP) %>%
+ ggplot() +
+ geom_rsi()
.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/810622doi: bioRxiv preprint 














Figure 2: Selection of five variables from the example_isolates data set: AMX (amoxicillin),
NIT (nitrofurantoin), FOX (fosfomycin), TMP (trimethoprim) and CIP (ciprofloxacin). These
variables are passed onto ggplot() and the new ’geom’ geom_rsi(), that automatically cal-
culates antimicrobial resistance, translates the abbreviations of antimicrobial agents and plots
the data.
In addition, the ggplot_rsi() function provides a wrapper around the geom_rsi() function,
taking any kind of ’data.frame’ as first input, so the function can be used after a pipe (%>%).
Prediction analyses can also be visualized with the AMR package. It extends the base R func-
tion plot(), but also contains a ggplot2 wrapper with the function ggplot_rsi_predict()
as shown in Figure 3.
R> example_isolates %>%
+ resistance_predict(col_ab = "TZP",
+ model = "binomial") %>%
+ ggplot_rsi_predict()
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Resistance Prediction of Piperacillin/tazobactam (TZP)
(n = 986, model: binomial)
Figure 3: Prediction of antimicrobial resistance to the TZP (piperacillin/tazobactam) vari-
able from the example_isolates data set. A regression model with a binomial cumulative
distribution function was chosen, assuming a period of very low resistance that cumulatively
increases over time. The ggplot_rsi_predict() function calculates the antimicrobial resis-
tance per year and plots the observations, followed by a prediction of the upcoming years.
The grey ribbon denotes the standard error of the mean, calculated as Sx̄ = s√n .
6. Reproducible example
A completely worked out example with fully annotated R code is available as supplementary
material, with file name complete_reproducible_example.R.
7. Summary
This paper demonstrates the AMR package and its foremost use for working with antimicro-
bial resistance data. It can be used to clean, enhance, and analyze such data according to
international recommendations and guidelines while incorporating scientifically reliable refer-
ence data on microbiological laboratory test results, antimicrobial agents, and the biological
taxonomy of microorganisms. Consequently, it allows for reproducible analyses, regardless of
the many possible ways in which raw and uncleaned data are stored in laboratory information
systems.
While the burden of antimicrobial resistance is increasing worldwide, reliable data and data
analyses are needed to better understand current and future developments. Open source
approaches, such as the AMR package for R, have the potential to help democratizing the
required tools in the field for researchers, clinicians, and policy makers alike. In organiza-
tions or countries with very limited resources, this free and open-source package could also
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overcome a financial limitation that would otherwise hinder antimicrobial resistance analysis
in these settings. Across settings, we believe the AMR package can be used to support clini-
cal decision-making by providing improved insight into current local and regional resistance
levels. Furthermore, data analysis approaches based on individual patient or microbiological
data, which the AMR package enables, fosters empowerment of laboratory staff, infection
control practitioners, and public health services.
8. Included data sets
• microorganisms
A ’data.frame’ containing 69,447 (sub)species with 16 columns comprising their com-
plete microbial taxonomy according to the Catalogue of Life (Roskov et al. 2019). In-
cluded microorganisms and their complete taxonomic tree of all included (sub)species
from kingdom to subspecies with year of scientific publication and responsible author(s):
– All 57,776 (sub)species from the kingdoms of Archaea, Bacteria, Chromista and
Protozoa;
– All 9,548 (sub)species from these orders of the kingdom of Fungi: Eurotiales, Ony-
genales, Pneumocystales, Saccharomycetales, Schizosaccharomycetales and Tremel-
lales;
– All 2,122 (sub)species from 46 other relevant genera from the kingdom of Animalia
(like Strongyloides and Taenia);
– All 24,253 previously accepted names of included (sub)species that have been tax-
onomically renamed.
The kingdom of Fungi is a very large taxon with almost 300,000 different (sub)species, of
which most are not microbial (but rather macroscopic, such as mushrooms). Therefore,
not all fungi fit the scope of the AMR package. By only including the aforementioned
taxonomic orders, the most relevant fungi are covered (such as all species of Aspergillus,
Candida, Cryptococcus, Histoplasma, Pneumocystis, Saccharomyces and Trichophyton).
• antibiotics
A ’data.frame’ containing 452 antibiotic agents with 13 columns. All entries in this
data set have three different identifiers: a human readable EARS-Net code (as used
by ECDC (European Centre for Disease Prevention and Control 2010) and WHONET
(WHO Collaborating Centre for Surveillance of Antimicrobial Resistance 2019) and pri-
marily used by this package), an ATC code (as used by the WHO (WHO Collaborating
Centre for Drug Statistics Methodology 2018)), and a CID code (Compound ID, as
used by PubChem (Kim et al. 2019)). The data set contains more than 5,000 official
brand names from many different countries, as found in PubChem. Other properties
in this data set are derived from one or more of these codes, such as official names of
pharmacological and chemical subgroups, and defined daily doses (DDD).
• antivirals
A ’data.frame’ containing 102 antiviral agents with 9 columns. Like the antibiotics
data set, it contains ATC codes (as used by the WHO (WHO Collaborating Centre
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for Drug Statistics Methodology 2018)), and a CID code (Compound ID, as used by
PubChem (Kim et al. 2019)), as well as the official name and defined daily dose (DDD)
for each antiviral agent.
• example_isolates
A ’data.frame’ containing test results of 2,000 microbial isolates. The data set reflects
real patient data and can be used to practice AMR analysis. It is structured in the typ-
ical format of laboratory information systems with one row per isolate and one column
per tested antimicrobial agent (i.e. an antibiogram).
• WHONET
A ’data.frame’ containing 500 observations and 53 columns, with the exact same struc-
ture as an export file from WHONET 2019 software (WHO Collaborating Centre for
Surveillance of Antimicrobial Resistance 2019). Such files can be used with the AMR
package, as this example data set demonstrates. The data itself was based on the
example_isolates data set.
Computational details
The results in this paper were obtained using R 3.6.1 in RStudio 1.2.5019 (RStudio Team
2019) with the AMR package 0.9.0, running under macOS Catalina 10.15.1.
R itself and all packages used are available from the Comprehensive R Archive Network
(CRAN) at https://CRAN.R-project.org/.
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